Pictet Asset Management LTD Trimmed Applied Matls (AMAT) Position by $634,500 as Share Price Rose; As Boston Scientific (BSX) Stock Rose, Artisan Partners Limited Partnership Has Decreased Its Position

December 8, 2017 - By Darrin Black

Pictet Asset Management Ltd decreased its stake in Applied Matls Inc (AMAT) by 1.69% based on its latest 2017Q2 regulatory filing with the SEC. Pictet Asset Management Ltd sold 14,100 shares as the company’s stock rose 23.58% with the market. The institutional investor held 819,965 shares of the technology company at the end of 2017Q2, valued at $37.62M, down from 834,065 at the end of the previous reported quarter. Pictet Asset Management Ltd who had been investing in Applied Matls Inc for a number of months, seems to be less bullish one the $55.78 billion market cap company. The stock increased 2.53% or $1.29 during the last trading session, reaching $52.3. About 14.69M shares traded or 29.66% up from the average. Applied Materials, Inc. (NASDAQ:AMAT) has risen 121.40% since December 8, 2016 and is uptrending. It has outperformed by 104.70% the S&P500.

Artisan Partners Limited Partnership decreased its stake in Boston Scientific Corp (BSX) by 13.7% based on its latest 2017Q2 regulatory filing with the SEC. Artisan Partners Limited Partnership sold 5.82 million shares as the company’s stock rose 4.02% with the market. The institutional investor held 36.65 million shares of the medical and dental instruments company at the end of 2017Q2, valued at $1.02B, down from 42.47M at the end of the previous reported quarter. Artisan Partners Limited Partnership who had been investing in Boston Scientific Corp for a number of months, seems to be less bullish one the $34.39 billion market cap company. The stock decreased 0.79% or $0.2 during the last trading session, reaching $25.04. About 9.67M shares traded or 37.16% up from the average. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since December 8, 2016 and is uptrending. It has outperformed by 2.42% the S&P500.

Investors sentiment increased to 1.03 in Q2 2017. Its up 0.14, from 0.89 in 2017Q1. It is positive, as 41 investors sold BSX shares while 173 reduced holdings. 56 funds opened positions while 165 raised stakes. 1.22 billion shares or 0.64% less from 1.23 billion shares in 2017Q1 were reported. The United Kingdom-based Bp Public Lc has invested 0.17% in Boston Scientific Corporation (NYSE:BSX). Stevens Cap Management LP invested 0.07% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Aureus Asset Mgmt Ltd Liability Corp holds 579,918 shares or 2.7% of its portfolio. Barometer Mgmt Incorporated has invested 0.57% in Boston Scientific Corporation (NYSE:BSX). Artisan Partners Partnership has invested 1.91% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Ghost Tree Cap Ltd owns 1.01% invested in Boston Scientific Corporation (NYSE:BSX) for 175,000 shares. Hanson Mcclain Inc holds 0% or 641 shares in its portfolio. Moreover, Mitsubishi Ufj & Corporation has 0.15% invested in Boston Scientific Corporation (NYSE:BSX). Bnp Paribas Arbitrage invested 0.07% in Boston Scientific Corporation (NYSE:BSX). Whittier invested in 0% or 65 shares. Geode Cap Management owns 12.40M shares. Pinnacle Ptnrs has invested 0.01% in Boston Scientific Corporation (NYSE:BSX). Lombard Odier Asset Mngmt (Switzerland) Sa has invested 0.11% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Lmr Limited Liability Partnership accumulated 0.18% or 101,082 shares. Ig Invest Management Limited reported 0.01% in Boston Scientific Corporation (NYSE:BSX).

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on February, 1. They expect $0.34 EPS, up 13.33% or $0.04 from last year’s $0.3 per share. BSX’s profit will be $466.89M for 18.41 P/E if the $0.34 EPS becomes a reality. After $0.31 actual EPS reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts 9.68% EPS growth.

Artisan Partners Limited Partnership, which manages about $53.26 billion US Long portfolio, upped its stake in Fedex Corp (NYSE:FDX) by 9,568 shares to 1.22 million shares, valued at $264.17 million in 2017Q2, according to the filing. It also increased its holding in Gartner Inc (NYSE:IT) by 649,942 shares in the quarter, for a total of 1.85 million shares, and has risen its stake in Grupo Supervielle S A.

More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: Prnewswire.com which released: “Boston Scientific To Participate In Piper Jaffray 29th Annual Healthcare …” on November 13, 2017, also Prnewswire.com with their article: “Boston Scientific Announces Update on LOTUS Edgeâ„¢ Aortic Valve System” published on November 29, 2017, Nasdaq.com published: “Associated Banc-corp Buys Boston Scientific Corp, Analog Devices Inc …” on November 13, 2017. More interesting news about Boston Scientific Corporation (NYSE:BSX) were released by: Globenewswire.com and their article: “Global Wearable Computing Market 2017-2022 with Medtronic, Garmin, Boston …” published on November 17, 2017 as well as Prnewswire.com‘s news article titled: “Boston Scientific To Participate In Stifel 2017 Healthcare Conference” with publication date: November 08, 2017.

Among 28 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 5 Hold. Therefore 82% are positive. Boston Scientific Corporation has $36 highest and $19 lowest target. $28.50’s average target is 13.82% above currents $25.04 stock price. Boston Scientific Corporation had 78 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Hold” rating by TheStreet on Thursday, August 13. As per Monday, September 28, the company rating was upgraded by Needham. The stock has “Buy” rating by BMO Capital Markets on Monday, June 19. The firm earned “Buy” rating on Thursday, October 6 by Citigroup. On Sunday, November 5 the stock rating was maintained by RBC Capital Markets with “Buy”. The firm has “Buy” rating given on Thursday, October 26 by Stifel Nicolaus. The firm earned “Buy” rating on Friday, April 28 by Needham. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by BMO Capital Markets on Thursday, August 31. The company was upgraded on Thursday, August 27 by Goldman Sachs. Needham maintained it with “Buy” rating and $32 target in Thursday, June 22 report.

Among 28 analysts covering Applied Materials Inc. (NASDAQ:AMAT), 27 have Buy rating, 0 Sell and 1 Hold. Therefore 96% are positive. Applied Materials Inc. has $76.0 highest and $12 lowest target. $52.43’s average target is 0.25% above currents $52.3 stock price. Applied Materials Inc. had 106 analyst reports since August 4, 2015 according to SRatingsIntel. Cowen & Co maintained it with “Outperform” rating and $32.50 target in Friday, August 19 report. On Friday, August 14 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The stock has “Outperform” rating by Cowen & Co on Wednesday, November 11. Deutsche Bank maintained the shares of AMAT in report on Friday, November 17 with “Buy” rating. B. Riley & Co maintained the stock with “Neutral” rating in Friday, February 19 report. Summit Research downgraded Applied Materials, Inc. (NASDAQ:AMAT) on Tuesday, August 11 to “Buy” rating. DA Davidson upgraded it to “Buy” rating and $28 target in Monday, June 27 report. The rating was maintained by UBS with “Buy” on Friday, May 20. The stock has “Buy” rating by DA Davidson on Monday, July 10. The firm has “Conviction Buy” rating by Goldman Sachs given on Wednesday, February 3.

Pictet Asset Management Ltd, which manages about $32.49 billion US Long portfolio, upped its stake in Stryker Corp (NYSE:SYK) by 47,060 shares to 1.03 million shares, valued at $146.64 million in 2017Q2, according to the filing. It also increased its holding in Nuance Communications Inc (NASDAQ:NUAN) by 223,993 shares in the quarter, for a total of 4.17 million shares, and has risen its stake in Infosys Ltd (NYSE:INFY).

More notable recent Applied Materials, Inc. (NASDAQ:AMAT) news were published by: Seekingalpha.com which released: “Looking Chipper: Buying This Dip In Applied Materials” on December 06, 2017, also Seekingalpha.com with their article: “The Applied Materials Super-Cycle Is In Full Swing” published on November 22, 2017, Seekingalpha.com published: “Applied Materials Is Weak Short Term For Semiconductors, But Strong For Displays” on November 29, 2017. More interesting news about Applied Materials, Inc. (NASDAQ:AMAT) were released by: Seekingalpha.com and their article: “Booming Chips” published on November 28, 2017 as well as Seekingalpha.com‘s news article titled: “Applied Materials: Business Diversity And Strong Growth At A Value Price” with publication date: December 07, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: